Overview Financials News + Filings Key Docs Charts Ownership Insiders
|
|
Sigyn Therapeutics, Inc. (RGNP)
|
|
| Credit Analysis |
|
|
|
|
Annual | Quarterly |
|
| In millions, except per share items | Dec-31-22 | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Nov-30-16 | Dec-31-15 |
| | Source | Source | Source | Source | Source | Source | Source | Source |
| Short-term debt | 3.3 | 1.3 | 1.0 | | 1.8 | 1.2 | | |
| Long-term debt | 2.3 | 0.7 | 0.6 | | 1.7 | 1.4 | | |
| Total debt | 5.6 | 2.0 | 1.7 | | 3.6 | 2.7 | | |
| Net debt | 5.5 | 1.7 | 1.6 | | 3.6 | 2.7 | | |
| |
| Debt to EBITDA | | | | | 19.2 | | | |
| Net debt to EBITDA | | | | | 19.2 | | | |
| |
| EBITDA interest coverage | | | | | 0.5 | | | |
|